ARCHIVES

FDA Moves To Revoke Avastin’s Breast Cancer Accelerated Approval, Genentech Vows To Fight

This article is from The Cancer Letter archive.

Vol. 36 No. 46 | December 17, 2010

Download PDF Visit The Full Archive

Related Articles

Fisher To Direct Wilmot CC

October 5, 2001

Top Officials Resign From San Antonio’s Institute for Drug Development.

January 26, 2007

NI Communications Effort, Saves By Congress, Now A Major National Cancer Program Resource

August 15, 1975

Frei, Freireich Share One GM Prize; Ames, Erikson Win Others

June 17, 1983

NCCN Guidelines Retain Avastin For Breast Cancer

October 22, 2010

CCRAC Approves New Grant Program For Studies Of Cancer Patient Compliance RFA to Be Issued

May 16, 1980